Imfinzi Euroopan unioni - suomi - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

LINEZOLID MYLAN 2 mg/ml infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

linezolid mylan 2 mg/ml infuusioneste, liuos

mylan ireland limited mylan ireland limited - linezolidum - infuusioneste, liuos - 2 mg/ml - linetsolidi

Dutasteride/Tamsulosinhydrochloride Mylan 0,5 mg / 0,4 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

dutasteride/tamsulosinhydrochloride mylan 0,5 mg / 0,4 mg kapseli, kova

mylan ab - dutasteride, tamsulosin hydrochloride - kapseli, kova - 0,5 mg / 0,4 mg - tamsulosiini ja dutasteridi

DUTASTERIDE MYLAN 0.5 mg kapseli, pehmeä Suomi - suomi - Fimea (Suomen lääkevirasto)

dutasteride mylan 0.5 mg kapseli, pehmeä

mylan ab - dutasteridum - kapseli, pehmeä - 0.5 mg - dutasteridi

Pluvicto Euroopan unioni - suomi - EMA (European Medicines Agency)

pluvicto

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - eturauhasen kasvaimet, kastraatio-resistentin - terapeuttiset radiofarmaseuttiset valmisteet - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech Euroopan unioni - suomi - EMA (European Medicines Agency)

human igg1 monoclonal antibody specific for human interleukin-1 alpha xbiotech

xbiotech germany gmbh - humaani iggl-monoklonaalinen vasta-aine, joka on spesifinen ihmisen interleukiini-1-alfalle - paksusuolen vajaatoiminta - antineoplastiset aineet - metastasoituneen paksu-ja peräsuolen syöpä.

Fenoflox vet 100 mg/ml injektioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

fenoflox vet 100 mg/ml injektioneste, liuos

chanelle pharmaceuticals manufacturing limited - enrofloxacin - injektioneste, liuos - 100 mg/ml - enrofloksasiini

Fenoflox vet 50 mg/ml injektioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

fenoflox vet 50 mg/ml injektioneste, liuos

chanelle pharmaceuticals manufacturing limited - enrofloxacin - injektioneste, liuos - 50 mg/ml - enrofloksasiini

Propofol Primex 10 mg/ml injektio/infuusioneste, emulsio Suomi - suomi - Fimea (Suomen lääkevirasto)

propofol primex 10 mg/ml injektio/infuusioneste, emulsio

primex pharmaceuticals oy - propofol - injektio/infuusioneste, emulsio - 10 mg/ml - propofoli

Solensia Euroopan unioni - suomi - EMA (European Medicines Agency)

solensia

zoetis belgium sa - frunevetmab - kipulääkkeet - kissat - for the alleviation of pain associated with osteoarthritis in cats.